The landscape of somatic copy-number alteration across human cancersRameen Beroukhim, Anthony Letai, Mitsuyoshi Urashima et al.|Nature|2010Cited by 4.1k
High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug responseHui Gao, Zongyao Wang, Joshua M. Korn et al.|Nature Medicine|2015Cited by 1.4k
Increased lysosomal biomass is responsible for the resistance of triple-negative breast cancers to CDK4/6 inhibitionAnne Fassl, Piotr Siciński, Christopher T. Brain et al.|Science Advances|2020Cited by 105
Supplementary Material 10Rameen Beroukhim, Anthony Letai, Craig H. Mermel et al.|Unknown|2014Cited by 0